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ClinicalVariable ACEI RX No ACEI RX p
Aae. veare & SD 74.1 + 11.8 75.6 + 12.1 0.05
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Male sex, OR 1.34 (95”/6cl, 1.04-1.74) 0.03
Ssrumcreatinine, mgldl 1.4 + 0.9 2.0 * 2.0 0.00001
Cardiomagaiypresent, OR 1,57 (95% Cl, 1.14-2.14) 0.005
LVejectionfractian,% 34.1 + 14.8 42.2 + 14.6 0.00001
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~ 198 +73 171 +55 175+26 159 *3I
EF (%) 23+ 7 26+ 9 23&3 23&5
Mass (g) 334*87 305+76 306+73 317 *42
MR (1+) 2.8+ 1.1 2.5+ 1.4 2.3+ 1,1 2.9 + 0,6”
An increase of > 5% in EF (+ responee)was obaavad in 40% of the patientsafterV and
none in C.
c V – response V + reapanee
LVEF 1 23i 3 25+ 5 19*7
LVEF 2 23& 5 23& 6 32+ 11**
A LVEF (%) O*5 –2 +4 13+ 6***
RVAC 1 46& 14 39+ 17 24& 14*
RVAC 2 33+ 18 24+ 10+ 52+ 6**
A RVAC (%) –13+ 18 -15 *14 28+ 11***
+P -=0.02 w+1, *P <0.02 Vs < Vs 1, * < Vs c
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Endpaint Warfarin No Werf Odds Ratia P
A1l-cauaemartality 17.5”A 18,1% 0.780 0.44
Any rehospitalization 48.8% 44.s% 1.274 0.36
CHF rehospitalization 32.5”A 23,1”h 1.670 0.07
Death or rehospitalization 53,2°h 50.3% 1.142 0.62
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